Ohio-headquartered CRO Ricerca Biosciences can put off its liquidation plans, as the company has found an acquirer to keep its doors open just ahead of a self-imposed deadline.
Ricerca Bioscience is looking to get bought, and if it can't, the Ohio-headquartered CRO is clearing the way for massive layoffs.
With the market for biosimilars expected to spiral, drug research providers Celerion and Ricerca Biosciences have allied to extend their services to customers developing copycat versions of...
MDS Pharma Services says that Ricerca Biosciences is buying its discovery and preclinical services business for $45 million. The price includes a $25 million note, $20 million in cash and a minority